INSMED Inc (INSM)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

17 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012201120102009
Revenue$606.4M$363.7M$305.2M$245.4M$188.5M$164.4M$136.5M$9.8M$0$0$0$11.5M$0$4.4M$6.9M$10.4M
Gross profit$112.3M$7.4M$0
Research & development$771.1M$598.4M$571.0M$397.5M$272.7M$181.2M$131.7M$145.3M$109.7M$122.7M$74.3M$56.3M$44.3M$29.8M$28.6M$4.7M$9.2M
Operating expenses$188.9M$173.4M$117.5M$87.4M$66.5M$42.4M$66.1M$15.0M$19.0M
Operating income−$1.25B−$878.3M−$709.6M−$457.3M−$375.1M−$265.2M−$235.2M−$307.3M−$188.9M−$173.4M−$117.5M−$87.4M−$55.0M−$42.4M−$61.7M−$8.1M−$8.7M
EBITDAderived−$1.23B−$867.2M−$704.1M−$452.0M−$366.0M−$256.1M−$230.0M−$303.7M−$186.0M−$171.0M−$115.5M−$86.3M−$54.3M−$41.9M−$61.4M−$8.0M−$8.0M
Net income−$1.28B−$913.8M−$749.6M−$481.5M−$434.7M−$294.1M−$254.3M−$324.3M−$192.6M−$176.3M−$118.2M−$79.2M−$56.1M−$41.4M−$59.7M−$6.4M$118.3M
Basic EPSper diluted share-$6.42-$5.57-$5.34-$3.91-$3.88-$3.01-$3.01-$4.22-$2.89-$2.85-$2.02-$1.84-$1.60-$1.56-$2.95-$0.49$9.31
Diluted EPSper diluted share-$6.42-$5.57-$5.34-$3.91-$3.88-$3.01-$3.01-$4.22-$2.89-$2.85-$2.02-$1.84-$1.60-$1.56-$2.95-$0.49$9.30

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys2$201.7K disclosed value
Sells (SEC code S)380$326.69M disclosed value
250 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 25, 2026Form 4 · 10b5-1Lewis WilliamChair and CEOSellCommon Stock1.3K$106.27$137.3K258.9K
Jun 25, 2026Form 4 · 10b5-1Lewis WilliamChair and CEOSellCommon Stock2.5K$105.27$258.5K260.2K
Jun 25, 2026Form 4 · 10b5-1Lewis WilliamChair and CEOSellCommon Stock3.7K$104.28$388.2K262.7K
Jun 25, 2026Form 4 · 10b5-1Lewis WilliamChair and CEOSellCommon Stock1.8K$103.10$189.3K266.4K
Jun 25, 2026Form 4 · 10b5-1Lewis WilliamChair and CEOSellCommon Stock12.1K$102.34$1.24M268.2K